{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:53:18Z","timestamp":1791395598722,"version":"4.3.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10291-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:24:11Z","timestamp":1779236651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bridging antiviral drug discovery with a large language model-powered framework"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8704-3949","authenticated-orcid":false,"given":"Boming","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1282-8975","authenticated-orcid":false,"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-9422","authenticated-orcid":false,"given":"Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-729X","authenticated-orcid":false,"given":"Fuping","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-5221","authenticated-orcid":false,"given":"Qinghua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"10291_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","volume":"22","author":"A von Delft","year":"2023","unstructured":"von Delft, A. et al. Accelerating antiviral drug discovery: lessons from COVID-19. Nat. Rev. Drug Discov. 22, 585\u2013603 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10291_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","volume":"155","author":"S Chaudhuri","year":"2018","unstructured":"Chaudhuri, S., Symons, J. A. & Deval, J. Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond. Antivir. Res. 155, 76\u201388 (2018).","journal-title":"Antivir. Res."},{"key":"10291_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12929-022-00852-9","volume":"29","author":"M Kumari","year":"2022","unstructured":"Kumari, M. et al. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. J. Biomed. Sci. 29, 68 (2022).","journal-title":"J. Biomed. Sci."},{"key":"10291_CR4","doi-asserted-by":"crossref","unstructured":"Ameratunga, R. et al. SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19? Antivir. Res.227, 105894 (2024).","DOI":"10.1016\/j.antiviral.2024.105894"},{"key":"10291_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","volume":"29","author":"WY Chi","year":"2022","unstructured":"Chi, W. Y. et al. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J. Biomed. Sci. 29, 82 (2022).","journal-title":"J. Biomed. Sci."},{"key":"10291_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12929-022-00847-6","volume":"29","author":"K Nepali","year":"2022","unstructured":"Nepali, K., Sharma, R., Sharma, S., Thakur, A. & Liou, J. P. Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal. J. Biomed. Sci. 29, 65 (2022).","journal-title":"J. Biomed. Sci."},{"key":"10291_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4155\/fmc-2019-0307","volume":"12","author":"N Berdigaliyev","year":"2020","unstructured":"Berdigaliyev, N. & Aljofan, M. An overview of drug discovery and development. Future Med. Chem. 12, 939\u2013947 (2020).","journal-title":"Future Med. Chem."},{"key":"10291_CR8","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.2174\/092986712801661112","volume":"19","author":"P Aparoy","year":"2012","unstructured":"Aparoy, P., Reddy, K. K. & Reddanna, P. Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors. Curr. Med. Chem. 19, 3763\u20133778 (2012).","journal-title":"Curr. Med. Chem."},{"key":"10291_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.257.5073.1078","volume":"257","author":"ID Kuntz","year":"1992","unstructured":"Kuntz, I. D. Structure-based strategies for drug design and discovery. Science 257, 1078\u20131082 (1992).","journal-title":"Science"},{"key":"10291_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42242-1","volume":"14","author":"OH Choung","year":"2023","unstructured":"Choung, O. H., Vianello, R., Segler, M., Stiefl, N. & Jimenez-Luna, J. Extracting medicinal chemistry intuition via preference machine learning. Nat. Commun. 14, 6651 (2023).","journal-title":"Nat. Commun."},{"key":"10291_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6","volume":"16","author":"RS Bohacek","year":"1996","unstructured":"Bohacek, R. S., McMartin, C. & Guida, W. C. The art and practice of structure-based drug design: a molecular modeling perspective. Med. Res. Rev. 16, 3\u201350 (1996).","journal-title":"Med. Res. Rev."},{"key":"10291_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan, J. et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 18, 463\u2013477 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10291_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0057-7","volume":"6","author":"J Jeon","year":"2014","unstructured":"Jeon, J. et al. A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Med. 6, 57 (2014).","journal-title":"Genome Med."},{"key":"10291_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1021\/ci500190p","volume":"54","author":"S Riniker","year":"2014","unstructured":"Riniker, S., Wang, Y., Jenkins, J. L. & Landrum, G. A. Using information from historical high-throughput screens to predict active compounds. J. Chem. Inf. Model 54, 1880\u20131891 (2014).","journal-title":"J. Chem. Inf. Model"},{"key":"10291_CR15","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/bioinformatics\/btx069","volume":"33","author":"WJ Godinez","year":"2017","unstructured":"Godinez, W. J., Hossain, I., Lazic, S. E., Davies, J. W. & Zhang, X. A multi-scale convolutional neural network for phenotyping high-content cellular images. Bioinformatics 33, 2010\u20132019 (2017).","journal-title":"Bioinformatics"},{"key":"10291_CR16","doi-asserted-by":"crossref","unstructured":"Fan, R. et al. A combined deep learning framework for mammalian m6A site prediction. Cell Genom. 4, 100697 (2024).","DOI":"10.1016\/j.xgen.2024.100697"},{"key":"10291_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fgene.2018.00242","volume":"9","author":"P Mamoshina","year":"2018","unstructured":"Mamoshina, P. et al. Machine learning on human muscle transcriptomic data for biomarker discovery and tissue-specific drug target identification. Front. Genet. 9, 242 (2018).","journal-title":"Front. Genet."},{"key":"10291_CR18","doi-asserted-by":"crossref","unstructured":"Kang, B., Fan, R., Cui, C. & Cui, Q. Comprehensive prediction and analysis of human protein essentiality based on a pretrained large language model. Nat. Comput. Sci. 5, 196\u2013206 (2024).","DOI":"10.1038\/s43588-024-00733-1"},{"key":"10291_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","volume":"379","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 379, 1123\u20131130 (2023).","journal-title":"Science"},{"key":"10291_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43214-1","volume":"14","author":"H Li","year":"2023","unstructured":"Li, H. et al. A knowledge-guided pre-training framework for improving molecular representation learning. Nat. Commun. 14, 7568 (2023).","journal-title":"Nat. Commun."},{"key":"10291_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41592-024-02305-7","volume":"21","author":"M Hao","year":"2024","unstructured":"Hao, M. et al. Large-scale foundation model on single-cell transcriptomics. Nat. Methods 21, 1481\u20131491 (2024).","journal-title":"Nat. Methods"},{"key":"10291_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.gpb.2019.04.003","volume":"17","author":"F Wan","year":"2019","unstructured":"Wan, F. et al. DeepCPI: a deep learning-based framework for large-scale in silico drug screening. Genomics Proteomics Bioinformatics 17, 478\u2013495 (2019).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10291_CR23","doi-asserted-by":"publisher","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H Ozturk","year":"2018","unstructured":"Ozturk, H., Ozgur, A. & Ozkirimli, E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics 34, i821\u2013i829 (2018).","journal-title":"Bioinformatics"},{"key":"10291_CR24","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","volume":"37","author":"T Nguyen","year":"2021","unstructured":"Nguyen, T. et al. GraphDTA: predicting drug-target binding affinity with graph neural networks. Bioinformatics 37, 1140\u20131147 (2021).","journal-title":"Bioinformatics"},{"key":"10291_CR25","doi-asserted-by":"publisher","first-page":"e1007129","DOI":"10.1371\/journal.pcbi.1007129","volume":"15","author":"I Lee","year":"2019","unstructured":"Lee, I., Keum, J. & Nam, H. DeepConv-DTI: prediction of drug-target interactions via deep learning with convolution on protein sequences. PLoS Comput. Biol. 15, e1007129 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"10291_CR26","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1093\/bioinformatics\/btaa524","volume":"36","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments. Bioinformatics 36, 4406\u20134414 (2020).","journal-title":"Bioinformatics"},{"key":"10291_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/bioinformatics\/btaa880","volume":"37","author":"K Huang","year":"2021","unstructured":"Huang, K., Xiao, C., Glass, L. M. & Sun, J. MolTrans: molecular interaction transformer for drug-target interaction prediction. Bioinformatics 37, 830\u2013836 (2021).","journal-title":"Bioinformatics"},{"key":"10291_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61745-7","volume":"16","author":"Q Zhao","year":"2025","unstructured":"Zhao, Q. et al. ColdstartCPI: induced-fit theory-guided DTI predictive model with improved generalization performance. Nat. Commun. 16, 6436 (2025).","journal-title":"Nat. Commun."},{"key":"10291_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57828-0","volume":"16","author":"Z Lu","year":"2025","unstructured":"Lu, Z. et al. DTIAM: a unified framework for predicting drug-target interactions, binding affinities and drug mechanisms. Nat. Commun. 16, 2548 (2025).","journal-title":"Nat. Commun."},{"key":"10291_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57536-9","volume":"16","author":"H Hadipour","year":"2025","unstructured":"Hadipour, H. et al. GraphBAN: An inductive graph-based approach for enhanced prediction of compound-protein interactions. Nat. Commun. 16, 2541 (2025).","journal-title":"Nat. Commun."},{"key":"10291_CR31","doi-asserted-by":"publisher","unstructured":"Chen, G., He, H., Lv, Q., Zhao, L. & Chen, C. Y. MMFA-DTA: multimodal feature attention fusion network for drug-target affinity prediction for drug repurposing against SARS-CoV-2. J. Chem. Theory Comput. https:\/\/doi.org\/10.1021\/acs.jctc.4c00663(2024).","DOI":"10.1021\/acs.jctc.4c00663"},{"key":"10291_CR32","unstructured":"Shin, B., Park, S., Kang, K. & Ho, J. C. In Machine Learning for Healthcare Conference 230\u2013248 (PMLR)."},{"key":"10291_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","volume":"18","author":"BR Beck","year":"2020","unstructured":"Beck, B. R., Shin, B., Choi, Y., Park, S. & Kang, K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput. Struct. Biotechnol. J. 18, 784\u2013790 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10291_CR34","doi-asserted-by":"publisher","first-page":"104676","DOI":"10.1016\/j.chemolab.2022.104676","volume":"230","author":"B Das","year":"2022","unstructured":"Das, B., Kutsal, M. & Das, R. Effective prediction of drug\u2013target interaction on HIV using deep graph neural networks. Chemometrics Intell. Lab. Syst. 230, 104676 (2022).","journal-title":"Chemometrics Intell. Lab. Syst."},{"key":"10291_CR35","doi-asserted-by":"crossref","unstructured":"Wang, S., Sun, Q., Xu, Y., Pei, J. & Lai, L. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2. Brief. Bioinform. 22, bbab211 (2021).","DOI":"10.1093\/bib\/bbab211"},{"key":"10291_CR36","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180\u2013D1192 (2024).","journal-title":"Nucleic Acids Res."},{"key":"10291_CR37","doi-asserted-by":"publisher","first-page":"W612","DOI":"10.1093\/nar\/gkv352","volume":"43","author":"M Davies","year":"2015","unstructured":"Davies, M. et al. ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res. 43, W612\u2013W620 (2015).","journal-title":"Nucleic Acids Res."},{"key":"10291_CR38","doi-asserted-by":"publisher","first-page":"D1633","DOI":"10.1093\/nar\/gkae1075","volume":"53","author":"T Liu","year":"2025","unstructured":"Liu, T. et al. BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data. Nucleic Acids Res. 53, D1633\u2013D1644 (2025).","journal-title":"Nucleic Acids Res."},{"key":"10291_CR39","first-page":"5281","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum, G. RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg. Landrum 8, 5281 (2013).","journal-title":"Greg. Landrum"},{"key":"10291_CR40","unstructured":"Ahmad, W., Simon, E., Chithrananda, S., Grand, G. & Ramsundar, B. Chemberta-2: Towards chemical foundation models. Preprint at https:\/\/arxiv.org\/abs\/2209.01712 (2022)."},{"key":"10291_CR41","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s42256-022-00580-7","volume":"4","author":"J Ross","year":"2022","unstructured":"Ross, J. et al. Large-scale chemical language representations capture molecular structure and properties. Nat. Mach. Intell. 4, 1256\u20131264 (2022).","journal-title":"Nat. Mach. Intell."},{"key":"10291_CR42","doi-asserted-by":"publisher","first-page":"025035","DOI":"10.1088\/2632-2153\/acdb30","volume":"4","author":"A Y\u00fcksel","year":"2023","unstructured":"Y\u00fcksel, A., Ulusoy, E., \u00dcnl\u00fc, A. & Do\u011fan, T. SELFormer: molecular representation learning via SELFIES language models. Mach. Learn. Sci. Technol. 4, 025035 (2023).","journal-title":"Mach. Learn. Sci. Technol."},{"key":"10291_CR43","unstructured":"Chithrananda, S., Grand, G. & Ramsundar, B. ChemBERTa: large-scale self-supervised pretraining for molecular property prediction. Preprint at https:\/\/arxiv.org\/abs\/2010.09885 (2020)."},{"key":"10291_CR44","unstructured":"Maziarka, \u0141. et al. Molecule attention transformer. Preprint at https:\/\/arxiv.org\/abs\/2002.08264 (2020)."},{"key":"10291_CR45","first-page":"12559","volume":"33","author":"Y Rong","year":"2020","unstructured":"Rong, Y. et al. Self-supervised graph transformer on large-scale molecular data. Adv. Neural Inf. Process. Syst. 33, 12559\u201312571 (2020).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10291_CR46","doi-asserted-by":"crossref","unstructured":"Zhou, G. et al. Uni-Mol: A Universal 3D Molecular Representation Learning Framework. In The Eleventh International Conference on Learning Representations (ICLR) (2023).","DOI":"10.26434\/chemrxiv-2022-jjm0j-v4"},{"key":"10291_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51844-2","volume":"15","author":"R Schmirler","year":"2024","unstructured":"Schmirler, R., Heinzinger, M. & Rost, B. Fine-tuning protein language models boosts predictions across diverse tasks. Nat. Commun. 15, 7407 (2024).","journal-title":"Nat. Commun."},{"key":"10291_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405840121","volume":"121","author":"S Sledzieski","year":"2024","unstructured":"Sledzieski, S. et al. Democratizing protein language models with parameter-efficient fine-tuning. Proc. Natl. Acad. Sci. USA. 121, e2405840121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10291_CR49","doi-asserted-by":"crossref","unstructured":"Meng, Z., Meng, Z., Yuan, K. & Ounis, I. FusionDTI: Fine-grained Binding Discovery with Token-level Fusion for Drug-Target Interaction. In Findings of the Association for Computational Linguistics: EMNLP (2025).","DOI":"10.18653\/v1\/2025.findings-emnlp.237"},{"key":"10291_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s42256-022-00605-1","volume":"5","author":"P Bai","year":"2023","unstructured":"Bai, P., Miljkovi\u0107, F., John, B. & Lu, H. Interpretable bilinear attention network with domain adaptation improves drug\u2013target prediction. Nat. Mach. Intell. 5, 126\u2013136 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"10291_CR51","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res. 52, D1265\u2013D1275 (2024).","journal-title":"Nucleic Acids Res."},{"key":"10291_CR52","unstructured":"Van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn Res. 9, 2579\u20132605 (2008)."},{"key":"10291_CR53","first-page":"1","volume":"1","author":"SG Deeks","year":"2015","unstructured":"Deeks, S. G., Overbaugh, J., Phillips, A. & Buchbinder, S. HIV infection. Nat. Rev. Dis. Prim. 1, 1\u201322 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10291_CR54","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.chembiol.2020.08.009","volume":"27","author":"F Vincent","year":"2020","unstructured":"Vincent, F. et al. Hit triage and validation in phenotypic screening: considerations and strategies. Cell Chem. Biol. 27, 1332\u20131346 (2020).","journal-title":"Cell Chem. Biol."},{"key":"10291_CR55","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ejmech.2017.04.070","volume":"135","author":"M Tonelli","year":"2017","unstructured":"Tonelli, M. et al. Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus. Eur. J. Med. Chem. 135, 467\u2013478 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"10291_CR56","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1021\/acs.jmedchem.6b01227","volume":"60","author":"H Ju","year":"2017","unstructured":"Ju, H. et al. Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives. J. Med. Chem. 60, 3533\u20133551 (2017).","journal-title":"J. Med. Chem."},{"key":"10291_CR57","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/jm801322h","volume":"52","author":"LH Jones","year":"2009","unstructured":"Jones, L. H. et al. Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays. J. Med. Chem. 52, 1219\u20131223 (2009).","journal-title":"J. Med. Chem."},{"key":"10291_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70267","volume":"97","author":"W Mao","year":"2025","unstructured":"Mao, W. et al. Antiviral activity of the MEK1\/2 inhibitor trametinib against lymphocytic choriomeningitis virus. J. Med. Virol. 97, e70267 (2025).","journal-title":"J. Med. Virol."},{"key":"10291_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01129-24","volume":"98","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication. J. Virol. 98, e0112924 (2024).","journal-title":"J. Virol."},{"key":"10291_CR60","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.bmcl.2013.12.070","volume":"24","author":"B C\u00f4t\u00e9","year":"2014","unstructured":"C\u00f4t\u00e9, B. et al. Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses. Bioorg. Med. Chem. Lett. 24, 917\u2013922 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10291_CR61","first-page":"663","volume":"94","author":"G Barillari","year":"1999","unstructured":"Barillari, G. et al. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94, 663\u2013672 (1999).","journal-title":"Blood"},{"key":"10291_CR62","doi-asserted-by":"publisher","first-page":"9969","DOI":"10.1128\/JVI.77.18.9969-9978.2003","volume":"77","author":"KL Graham","year":"2003","unstructured":"Graham, K. L. et al. Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J. Virol. 77, 9969\u20139978 (2003).","journal-title":"J. Virol."},{"key":"10291_CR63","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1182\/blood-2003-05-1522","volume":"102","author":"KA Weigel-Kelley","year":"2003","unstructured":"Weigel-Kelley, K. A., Yoder, M. C. & Srivastava, A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102, 3927\u20133933 (2003).","journal-title":"Blood"},{"key":"10291_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39856-w","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Sequence-based drug design as a concept in computational drug design. Nat. Commun. 14, 4217 (2023).","journal-title":"Nat. Commun."},{"key":"10291_CR65","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 52, D1465\u2013D1477 (2024).","journal-title":"Nucleic Acids Res."},{"key":"10291_CR66","unstructured":"Paszke, A. et al. Automatic differentiation in pytorch. In 31st Conference on Neural Information Processing Systems (NIPS, 2017)."},{"key":"10291_CR67","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373\u2013D1380 (2023).","journal-title":"Nucleic Acids Res."},{"key":"10291_CR68","doi-asserted-by":"crossref","unstructured":"Yang, M. et al. Uni-GBSA: an open-source and web-based automatic workflow to perform MM\/GB(PB)SA calculations for virtual screening. Brief. Bioinform. 24, bbad218 (2023).","DOI":"10.1093\/bib\/bbad218"},{"key":"10291_CR69","unstructured":"Boming, K. Bridging antiviral drug discovery with a large language model-powered framework v. v1. Zenodo (2026)."},{"key":"10291_CR70","unstructured":"Boming, K. DeepAVC: bridging antiviral drug discovery with a large language model-powered framework v. v1.0.0. Zenodo (2026)."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10291-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:11:15Z","timestamp":1786317075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10291"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10291-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1069"}}